Codexis(CDXS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CDXS Codexis

Trading 12-22 15:20:33 EST

1.69

+0.03

+1.51%

High1.75	Low1.68	Vol1.20M
Open1.68	D1 Closing1.66	Amplitude4.22%
Mkt Cap152.20M	Tradable Cap113.88M	Total Shares90.32M
T/O2.06M	T/O Rate1.78%	Tradable Shares67.59M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CDXS","market":"US","secType":"STK","nameCN":"Codexis","latestPrice":1.685,"timestamp":1766434830410,"preClose":1.66,"halted":0,"volume":1203390,"delay":0,"floatShares":67586200,"shares":90324383,"eps":-0.753494,"marketStatus":"Trading","change":0.025,"latestTime":"12-22 15:20:33 EST","open":1.68,"high":1.75,"low":1.68,"amount":2057053.5659969999,"amplitude":0.042169,"askPrice":1.69,"askSize":5783,"bidPrice":1.68,"bidSize":13647,"shortable":3,"etf":0,"ttmEps":-0.753494,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1271908800000,"exchange":"NASDAQ","adjPreClose":1.66,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.66,"latestTime":"08:41 EST","volume":203,"amount":345.0000022,"timestamp":1766410891803},"postHourTrading":{"tag":"盘后","latestPrice":1.66,"preClose":1.66,"latestTime":"16:36 EST","volume":196336,"amount":325887.3445,"timestamp":1766180168497},"volumeRatio":1.117241,"impliedVol":1.1923,"impliedVolPercentile":0.66},"requestUrl":"/m/hq/s/CDXS","defaultTab":"news","newsList":[{"id":"2588706191","title":"Opaleye Management Inc. Reports Disposal of Codexis Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706191","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588706191?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:42","pubTimestamp":1764628938,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, reported a disposal of common shares of Codexis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDLbfrfqk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Opaleye Management Inc. Reports Disposal of Codexis Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDXS"],"gpt_icon":0},{"id":"2586409435","title":"Codexis Director Dennis P. Wolf Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586409435","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586409435?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:19","pubTimestamp":1764105568,"startTime":"0","endTime":"0","summary":"Dennis P. Wolf, Director, reported a disposal of common shares of Codexis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL3Hpsj1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Codexis Director Dennis P. Wolf Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2585454342","title":"U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt Hotels","url":"https://stock-news.laohu8.com/highlight/detail?id=2585454342","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585454342?lang=en_us&edition=fundamental","pubTime":"2025-11-24 16:05","pubTimestamp":1763971553,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt HotelsNov 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nL4N3X00BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","EXAS","GPN","CPRT","FISV","RBA","VEEV","BK4535","RIGL","BDN","LU1923622291.USD","CVNA","CPAY","FLUT","IMRX","LSPD","LU0211331839.USD","LU0354030438.USD","CDXS","LU2449936058.SGD","LB","LU1861558580.USD","BK4007","VNO","LU0476273544.USD","LU1861559042.SGD","CF","BK4099","LU0588546209.SGD","ALHC","NAVN","PRKS","STLA","LU0306807586.USD","LU0321505439.SGD","LU2298321311.HKD","MOS","AZTA","BMY","BLTE","BJ","WEX","COGT","HSBA.UK","LU1917777945.USD","H","GAP","TSCO","BK4559"],"gpt_icon":1},{"id":"2585141437","title":"Codexis Inc :  Piper Sandler Cuts Target Price to $9 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585141437?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:49","pubTimestamp":1763956170,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3WY02W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDXS"],"gpt_icon":0},{"id":"2584677837","title":"Codexis Inc. Files Initial Statement of Beneficial Ownership for CSO Stefan Lutz","url":"https://stock-news.laohu8.com/highlight/detail?id=2584677837","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584677837?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:11","pubTimestamp":1763417473,"startTime":"0","endTime":"0","summary":"Codexis Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Stefan Lutz as the beneficial owner, who serves as the company's Chief Scientific Officer . The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL3DDhvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2583588650","title":"Opaleye Management Inc. Reports Disposal of Codexis Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583588650","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583588650?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:07","pubTimestamp":1762981620,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner of Codexis Inc., reported a disposal of common shares of Codexis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3xcSYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Opaleye Management Inc. Reports Disposal of Codexis Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDXS"],"gpt_icon":0},{"id":"2582487205","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582487205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582487205?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:17","pubTimestamp":1762784253,"startTime":"0","endTime":"0","summary":"In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Codexis, with a price target of $5.00. According to TipRan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-codexis-cdxs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-codexis-cdxs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","CDXS"],"gpt_icon":0},{"id":"2582304872","title":"Codexis Signs Lease for New GMP Manufacturing Facility in California","url":"https://stock-news.laohu8.com/highlight/detail?id=2582304872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582304872?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:00","pubTimestamp":1762783252,"startTime":"0","endTime":"0","summary":"Codexis Inc. has announced the signing of a lease for a new 34,000 square foot GMP manufacturing facility in Hayward, California. This expansion will enable the company to increase its capabilities in the GMP manufacturing of siRNA and other oligonucleotides using its ECO Synthesis platform. The facility, designed for flexibility, will also support the production of high-quality purified enzymes. Modifications to the facility are expected to begin in early 2026, underscoring Codexis's commitment to supporting early clinical trials and adapting to evolving business needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via GlobeNewswire  on November 10, 2025, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL7H4W9g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4112","LU2095319765.USD","IE00B3QW5Z07.USD","LU0314104364.USD","CDXS","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","BK4588","BK4121"],"gpt_icon":0},{"id":"2581884907","title":"Cantor Fitzgerald Keeps Their Buy Rating on Codexis (CDXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581884907","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581884907?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:06","pubTimestamp":1762528019,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Codexis, with a price target of $11.00. Kluska cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-codexis-cdxs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-codexis-cdxs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDXS"],"gpt_icon":0},{"id":"2581024023","title":"Codexis Announces Q3 2025 Results and Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2581024023","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581024023?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:16","pubTimestamp":1762488996,"startTime":"0","endTime":"0","summary":"Codexis ( ($CDXS) ) has released its Q3 earnings. Here is a breakdown of the information Codexis presented to its investors. Codexis, Inc. is a bio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/codexis-announces-q3-2025-results-and-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/codexis-announces-q3-2025-results-and-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CDXS"],"gpt_icon":0},{"id":"2581444026","title":"Codexis Faces Uncertainty Amid Leadership Changes and Strategic Shifts, Leading to Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581444026","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581444026?lang=en_us&edition=fundamental","pubTime":"2025-11-07 10:25","pubTimestamp":1762482325,"startTime":"0","endTime":"0","summary":"Analyst Brendan Smith from TD Cowen maintained a Hold rating on Codexis and decreased the price target to $2.00 from $3.00. Brendan Smith has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/codexis-faces-uncertainty-amid-leadership-changes-and-strategic-shifts-leading-to-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/codexis-faces-uncertainty-amid-leadership-changes-and-strategic-shifts-leading-to-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDXS"],"gpt_icon":0},{"id":"2581042568","title":"Codexis posts Q3 revenue of $8.6 million with net loss of $19.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581042568","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581042568?lang=en_us&edition=fundamental","pubTime":"2025-11-07 07:42","pubTimestamp":1762472544,"startTime":"0","endTime":"0","summary":"Codexis Inc. reported total revenue of $8.6 million for the third quarter of 2025, compared to $12.8 million in the same period in 2024. Product gross margin improved to 64%, up from 61% the previous year. Research and development expenses were $13.9 million, while selling, general and administrative expenses totaled $11.2 million. The company reported a net loss of $19.6 million, or $0.22 per share, compared to a net loss of $20.6 million, or $0.29 per share, in the third quarter of 2024. Business highlights include a $37.8 million supply assurance agreement with Merck, expected to provide cash by the end of 2025, and a planned lease of a 34,000 square foot GMP facility. Codexis also noted continued commercial progress with 11 customers and 40 prospects in its pipeline. The company is reiterating its 2025 guidance and expects to issue 2026 guidance in early 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLh7qcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0122379950.USD","SG9999014559.SGD","LU1291159041.SGD","IE00BN8TJ469.HKD","LU0211331839.USD","MRK","LU1941712348.USD","SG9999014567.USD","LU1162221912.USD","BK4588","LU0098860793.USD","BK4121","LU0266013472.USD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU0106261372.USD","LU1585245621.USD","LU1116320901.HKD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","IE0009355771.USD","IE00BBT3K403.USD","LU2324357040.USD","LU1116320737.USD","LU1035773651.USD","LU1934455194.USD","LU2023250843.SGD","LU1983299246.USD","BK4559","LU0320765489.SGD","LU1069347547.HKD","BK4550","LU0965509101.SGD","LU2461242641.AUD","SG9999001176.SGD","LU0203347892.USD","SG9999002232.USD","LU1917777945.USD","LU1430594728.SGD","LU0985320562.USD","CDXS","LU2106854487.HKD","SG9999013999.USD","LU1066051225.USD","LU0203345920.USD","IE00B2B36J28.USD","BK4585"],"gpt_icon":0},{"id":"2581041140","title":"Codexis Down on 3Q Rev Decline, CEO Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2581041140","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581041140?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:48","pubTimestamp":1762469280,"startTime":"0","endTime":"0","summary":"Shares for Codexis were falling after the biotechnology company reported third-quarter earnings and sales that disappointed Wall Street.The stock fell 21% to $1.60 in after-hours trading Thursday. Ahead of the market close, shares were already down 57% year to date.Codexis reported a loss of $19.6 million, or 22 cents a share for the quarter ended Sept. 30, compared with a loss of $20.6 million, or 29 cents a share. Analysts polled by FactSet expected a more shallow loss of 15 cents a share.Revenue declined to $8.6 million in the third quarter from $12.8 million in the year-ago quarter due to variability in customers' manufacturing schedules and clinical trial progression. Analysts expected $18.5 million.Codexis said it has appointed Alison Moore as its next chief executive, succeeding Stephen Dilly, who will remain chairman. As it enacted leadership changes, the company cut 46 jobs, or about 24% of its workforce in November.The company also said it signed a $37.8 million supply assura","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDXS"],"gpt_icon":0},{"id":"2581204167","title":"BRIEF-Codexis Inc - Announces Workforce Reduction Of About 24% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581204167","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581204167?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:46","pubTimestamp":1762469164,"startTime":"0","endTime":"0","summary":"BRIEF-Codexis Inc - Announces Workforce Reduction Of About 24% - SEC FilingCodexis Inc CDXS.O:CODEXIS INC - ANNOUNCES WORKFORCE REDUCTION OF ABOUT 24% - SEC FILINGCODEXIS: WORKFORCE REDUCTION TO RESULT IN RECOGNITION OF ADDITIONAL EXPENSE OF ABOUT $3.5 MILLIONCODEXIS: ADDITIONAL EXPENSE TO BE RECOGNIZED IN Q4Source text: [ID:n0001193125-25-269716]Further company coverage: CDXS.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2581041368","title":"Codexis reports Q3 EPS (22c), consensus (13c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581041368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581041368?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:35","pubTimestamp":1762468534,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $8.6M, consensus $18.52M. “We’ve had a very exciting and important few months that have set us up very well for the changes we a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/codexis-reports-q3-eps-22c-consensus-13c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/codexis-reports-q3-eps-22c-consensus-13c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDXS"],"gpt_icon":0},{"id":"2581560045","title":"Codexis Globe Q3 EPS $-0.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2581560045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581560045?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:44","pubTimestamp":1762465481,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXEDC550:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2581043982","title":"Codexis: Workforce Reduction to Result in Recognition of Additional Expense of About $3.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581043982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581043982?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:31","pubTimestamp":1762464668,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2AR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2581048484","title":"Codexis Q3 EPS $(0.22) Misses $(0.15) Estimate, Sales $8.601M Miss $18.510M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581048484","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581048484?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:23","pubTimestamp":1762464237,"startTime":"0","endTime":"0","summary":"Codexis Q3 EPS $(0.22) Misses $(0.15) Estimate, Sales $8.601M Miss $18.510M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48704460/codexis-q3-eps-0-22-misses-0-15-estimate-sales-8-601m-miss-18-510m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Codexis Q3 EPS $(0.22) Misses $(0.15) Estimate, Sales $8.601M Miss $18.510M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDXS"],"gpt_icon":0},{"id":"2581049743","title":"Codexis Inc - Cash Runway Extended Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2581049743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581049743?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:21","pubTimestamp":1762464103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA2PH7ZH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDXS","BK4121"],"gpt_icon":0},{"id":"2580978756","title":"Codexis (CDXS) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2580978756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580978756?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:36","pubTimestamp":1762270601,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt reiterated a Buy rating on Codexis today. The company’s shares opened today at $2.23. Hewitt covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/codexis-cdxs-gets-a-buy-from-craig-hallum-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/codexis-cdxs-gets-a-buy-from-craig-hallum-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4588","LABU","BK4121","CDXS","BK4581","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codexis.com","stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0247},{"period":"3month","weight":-0.3224},{"period":"6month","weight":-0.2751},{"period":"1year","weight":-0.6758},{"period":"ytd","weight":-0.652}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.049152},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.016721},{"month":3,"riseRate":0.533333,"avgChangeRate":0.009068},{"month":4,"riseRate":0.266667,"avgChangeRate":-0.080381},{"month":5,"riseRate":0.375,"avgChangeRate":-0.036697},{"month":6,"riseRate":0.5,"avgChangeRate":0.030382},{"month":7,"riseRate":0.5,"avgChangeRate":0.025133},{"month":8,"riseRate":0.5,"avgChangeRate":-0.053581},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.004283},{"month":10,"riseRate":0.4375,"avgChangeRate":0.022437},{"month":11,"riseRate":0.5,"avgChangeRate":0.081236},{"month":12,"riseRate":0.625,"avgChangeRate":0.038284}],"exchange":"NASDAQ","name":"Codexis","nameEN":"Codexis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Codexis(CDXS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Codexis(CDXS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Codexis,CDXS,Codexis股票,Codexis股票老虎,Codexis股票老虎国际,Codexis行情,Codexis股票行情,Codexis股价,Codexis股市,Codexis股票价格,Codexis股票交易,Codexis股票购买,Codexis股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Codexis(CDXS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Codexis(CDXS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction